Skip secondary menu

Neurodegeneration


The Neurodegeneration program area portfolio consists of research on adult onset neurodegenerative diseases of all types, broadly focusing on pathogenesis, treatment and prevention. Research on the normal structure and function of neural systems is also included to enable identification of intervention strategies. The role of the programmatic team is to develop, implement and manage these research programs and to promote the translation of research findings into clinical practice.  Included in the portfolio are topics such as neuronal cell death, protein misfolding, aggregation, and  processing, mitochondrial pathologies, epidemiological studies, genetic studies including GWAS, biomarker studies, clinical studies including deep brain stimulation and gene therapy, and translational projects that will accelerate bench to bedside therapies for neurodegenerative disorders.

More Information on the Neurodegeneration program area.

Funding Initiatives in this category: